| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Sep, 2017 |
| Sales | 27,510 | 27,440 | 11,040 | 6,580 | -50,350 |
| Sales Growth | +0.26% | +148.55% | +67.78% | +113.07% | -57.94% |
| Net Income | -47,720 | -48,470 | -38,960 | -18,010 | 0 |
| Net Income Growth | +1.55% | -24.41% | -116.32% | unch | unch |
Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Telesis Bio is an automated multi-omic and synthetic biology solutions company. Its BioXp(R) system consolidates, automates and optimizes the entire synthesis, cloning and amplification workflow. Telesis Bio, formerly known as Codex DNA Inc., is based in SAN DIEGO.
Fiscal Year End Date: 12/31